医学
重症监护医学
重症监护室
抗生素治疗
抗生素
抗生素耐药性
抗生素管理
管理(神学)
困境
政治学
生物
微生物学
政治
认识论
哲学
法学
作者
Mehreen Kisat,Ben L. Zarzaur
标识
DOI:10.1016/j.suc.2021.09.007
摘要
Antibiotic resistance is a public health concern. A critical care clinician is faced with a clinical dilemma of using the appropriate treatment without compromising the antibiotic armamentarium. Postoperative and trauma patients in the intensive care unit (ICU) pose a unique challenge of mounting a systemic inflammatory response, which makes it even more difficult to differentiate inflammation from infection. The decision for type of empirical therapy should be individualized to the patient and local ecology data and resistance profiles. After initiation of empirical therapy, deescalation should be done once microbiology data are available. Antibiotic stewardship programs are essential in the ICU.
科研通智能强力驱动
Strongly Powered by AbleSci AI